O	0	6	Malate	Malate	JJ	B-NP
O	6	7	-	-	HYPH	I-NP
O	7	14	citrate	citrate	NN	I-NP
O	15	20	cycle	cycle	NN	I-NP
O	21	27	during	during	IN	B-PP
O	28	38	glycolysis	glycolysis	NN	B-NP
O	39	42	and	and	CC	I-NP
O	43	57	glutaminolysis	glutaminolysis	NN	I-NP
O	58	60	in	in	IN	B-PP
B-Cell	61	68	Ehrlich	Ehrlich	NNP	B-NP
I-Cell	69	76	ascites	ascite	VBZ	B-VP
I-Cell	77	82	tumor	tumor	NN	B-NP
I-Cell	83	88	cells	cell	NNS	I-NP
O	88	89	.	.	.	O

O	90	93	The	The	DT	B-NP
O	94	100	malate	malate	NN	I-NP
O	100	101	-	-	HYPH	I-NP
O	101	108	citrate	citrate	NN	I-NP
O	109	114	cycle	cycle	NN	I-NP
O	115	118	was	be	VBD	B-VP
O	119	126	studied	study	VBN	I-VP
O	127	133	during	during	IN	B-PP
O	134	141	aerobic	aerobic	JJ	B-NP
O	142	152	glycolysis	glycolysis	NN	I-NP
O	153	156	and	and	CC	I-NP
O	157	171	glutaminolysis	glutaminolysis	NN	I-NP
O	172	174	in	in	IN	B-PP
O	175	176	a	a	DT	B-NP
B-Cell	177	183	strain	strain	NN	I-NP
O	184	186	of	of	IN	B-PP
B-Cell	187	194	Ehrlich	Ehrlich	NNP	B-NP
I-Cell	195	202	ascites	ascite	VBZ	B-VP
I-Cell	203	208	tumor	tumor	NN	B-NP
I-Cell	209	214	cells	cell	NNS	I-NP
O	215	220	which	which	WDT	B-NP
O	221	227	showed	show	VBD	B-VP
O	228	229	a	a	DT	B-NP
O	230	234	very	very	RB	I-NP
O	235	238	low	low	JJ	I-NP
O	239	245	malate	malate	NN	I-NP
O	245	246	-	-	HYPH	B-NP
O	246	255	aspartate	aspartate	NN	I-NP
O	256	263	shuttle	shuttle	NN	I-NP
O	264	270	system	system	NN	I-NP
O	271	279	activity	activity	NN	I-NP
O	279	280	.	.	.	O

O	281	284	The	The	DT	B-NP
O	285	297	experimental	experimental	JJ	I-NP
O	298	306	approach	approach	NN	I-NP
O	307	315	includes	include	VBZ	B-VP
O	315	316	:	:	:	O
O	317	327	estimation	estimation	NN	B-NP
O	328	330	of	of	IN	B-PP
B-Cellular_component	331	344	mitochondrial	mitochondrial	JJ	B-NP
O	345	348	NAD	NAD	NN	I-NP
O	348	349	[	[	(	O
O	349	350	P	P	NN	B-NP
O	350	351	]	]	)	O
O	351	352	+	+	SYM	B-NP
O	352	353	-	-	HYPH	B-NP
O	353	362	dependent	dependent	JJ	I-NP
O	363	368	malic	malic	JJ	I-NP
O	369	375	enzyme	enzyme	NN	I-NP
O	376	384	activity	activity	NN	I-NP
O	384	385	;	;	:	O
O	386	397	respiratory	respiratory	JJ	B-NP
O	398	406	activity	activity	NN	I-NP
O	407	409	of	of	IN	B-PP
O	410	417	freshly	freshly	RB	B-NP
O	418	427	harvested	harvest	VBN	I-NP
O	428	430	or	or	CC	I-NP
O	431	437	fasted	fast	VBN	I-NP
B-Cell	438	443	cells	cell	NNS	I-NP
O	443	444	,	,	,	B-PP
O	445	448	and	and	CC	I-PP
O	449	451	of	of	IN	B-PP
O	452	460	isolated	isolate	VBN	B-NP
B-Cellular_component	461	473	mitochondria	mitochondrion	NNS	I-NP
O	473	474	;	;	:	O
O	475	478	and	and	CC	O
O	479	492	determination	determination	NN	B-NP
O	493	495	of	of	IN	B-PP
O	496	499	the	the	DT	B-NP
O	500	511	metabolites	metabolite	NNS	I-NP
O	512	520	involved	involve	VBN	B-VP
O	521	523	in	in	IN	B-PP
O	524	527	the	the	DT	B-NP
O	528	538	glycolytic	glycolytic	JJ	I-NP
O	539	542	and	and	CC	I-NP
O	543	557	glutaminolytic	glutaminolytic	JJ	I-NP
O	558	566	pathways	pathway	NNS	I-NP
O	566	567	.	.	.	O

O	568	571	The	The	DT	B-NP
O	572	579	results	result	NNS	I-NP
O	580	587	suggest	suggest	VBP	B-VP
O	588	592	that	that	IN	B-SBAR
O	593	595	in	in	IN	B-PP
O	596	600	this	this	DT	B-NP
B-Cell	601	607	strain	strain	NN	I-NP
O	607	608	,	,	,	O
O	609	612	the	the	DT	B-NP
O	613	619	malate	malate	NN	I-NP
O	619	620	-	-	HYPH	B-NP
O	620	627	citrate	citrate	NN	I-NP
O	628	635	shuttle	shuttle	NN	I-NP
O	636	638	is	be	VBZ	B-VP
O	639	642	not	not	RB	O
O	643	645	an	an	DT	B-NP
O	646	655	effective	effective	JJ	I-NP
O	656	663	pathway	pathway	NN	I-NP
O	664	667	for	for	IN	B-PP
O	668	680	transferring	transfer	VBG	B-VP
O	681	691	glycolytic	glycolytic	JJ	B-NP
O	692	700	reducing	reduce	VBG	I-NP
O	701	712	equivalents	equivalent	NNS	I-NP
O	713	717	from	from	IN	B-PP
B-Organism_substance	718	725	cytosol	cytosol	NN	B-NP
O	726	728	to	to	TO	B-PP
B-Cellular_component	729	741	mitochondria	mitochondrion	NNS	B-NP
O	741	742	.	.	.	O

O	743	747	Less	Less	RBR	B-NP
O	748	752	than	than	IN	I-NP
O	753	755	15	15	CD	I-NP
O	755	756	%	%	NN	I-NP
O	757	759	of	of	IN	B-PP
O	760	763	the	the	DT	B-NP
O	764	771	glucose	glucose	NN	I-NP
O	772	778	uptake	uptake	NN	I-NP
O	779	782	was	be	VBD	B-VP
O	783	791	affected	affect	VBN	I-VP
O	792	794	by	by	IN	B-PP
O	795	798	the	the	DT	B-NP
O	799	800	1	1	CD	I-NP
O	800	801	,	,	,	I-NP
O	801	802	2	2	CD	I-NP
O	802	803	,	,	,	I-NP
O	803	804	3	3	CD	I-NP
O	804	805	-	-	HYPH	I-NP
O	805	826	benzenetricarboxylate	benzenetricarboxylate	NN	I-NP
O	827	837	inhibition	inhibition	NN	I-NP
O	838	840	of	of	IN	B-PP
O	841	844	the	the	DT	B-NP
O	845	851	malate	malate	NN	I-NP
O	851	852	-	-	HYPH	B-NP
O	852	859	citrate	citrate	NN	I-NP
O	860	867	shuttle	shuttle	NN	I-NP
O	867	868	.	.	.	O

O	869	877	Moreover	Moreover	RB	B-ADVP
O	877	878	,	,	,	O
O	879	881	in	in	IN	B-PP
O	882	885	the	the	DT	B-NP
O	886	894	presence	presence	NN	I-NP
O	895	897	of	of	IN	B-PP
O	898	905	glucose	glucose	NN	B-NP
O	905	906	,	,	,	O
O	907	910	the	the	DT	B-NP
O	911	917	malate	malate	NN	I-NP
O	917	918	-	-	HYPH	B-NP
O	918	925	citrate	citrate	NN	I-NP
O	926	931	cycle	cycle	NN	I-NP
O	932	935	did	do	VBD	B-VP
O	936	939	not	not	RB	I-VP
O	940	946	appear	appear	VB	I-VP
O	947	949	to	to	TO	I-VP
O	950	954	play	play	VB	I-VP
O	955	957	an	an	DT	B-NP
O	958	967	important	important	JJ	I-NP
O	968	972	role	role	NN	I-NP
O	973	975	in	in	IN	B-PP
O	976	979	the	the	DT	B-NP
O	980	994	glutaminolytic	glutaminolytic	JJ	I-NP
O	995	1002	process	process	NN	I-NP
O	1002	1003	.	.	.	O

O	1004	1007	The	The	DT	B-NP
O	1008	1015	present	present	JJ	I-NP
O	1016	1020	work	work	NN	I-NP
O	1021	1029	supports	support	VBZ	B-VP
O	1030	1033	and	and	CC	I-VP
O	1034	1041	extends	extend	VBZ	I-VP
O	1042	1045	the	the	DT	B-NP
O	1046	1053	finding	finding	NN	I-NP
O	1054	1056	of	of	IN	B-PP
O	1057	1065	previous	previous	JJ	B-NP
O	1066	1073	studies	study	NNS	I-NP
O	1073	1074	,	,	,	O
O	1075	1080	since	since	IN	B-SBAR
O	1081	1084	the	the	DT	B-NP
O	1085	1092	results	result	NNS	I-NP
O	1093	1099	showed	show	VBD	B-VP
O	1100	1104	that	that	IN	B-SBAR
O	1105	1108	the	the	DT	B-NP
O	1109	1116	glucose	glucose	NN	I-NP
O	1117	1127	metabolism	metabolism	NN	I-NP
O	1128	1137	depressed	depress	VBD	B-VP
O	1138	1141	the	the	DT	B-NP
O	1142	1151	oxidative	oxidative	JJ	I-NP
O	1152	1161	processes	process	NNS	I-NP
O	1162	1164	in	in	IN	B-PP
B-Cancer	1165	1172	Ehrlich	Ehrlich	NNP	B-NP
I-Cancer	1173	1180	ascites	ascite	VBZ	B-VP
I-Cancer	1181	1186	tumor	tumor	NN	B-NP
B-Cellular_component	1187	1199	mitochondria	mitochondrion	NNS	I-NP
O	1199	1200	,	,	,	O
O	1201	1204	not	not	RB	B-ADVP
O	1205	1209	only	only	RB	I-ADVP
O	1210	1215	alone	alone	RB	I-ADVP
O	1215	1216	,	,	,	O
O	1217	1220	but	but	CC	B-CONJP
O	1221	1225	also	also	RB	I-CONJP
O	1226	1228	in	in	IN	B-PP
O	1229	1232	the	the	DT	I-PP
O	1233	1241	presence	presence	NN	I-PP
O	1242	1244	of	of	IN	I-PP
O	1245	1254	glutamine	glutamine	NN	B-NP
O	1254	1255	.	.	.	O

O	1256	1269	Interestingly	Interestingly	RB	B-ADVP
O	1269	1270	,	,	,	O
O	1271	1274	the	the	DT	B-NP
O	1275	1279	high	high	JJ	I-NP
O	1280	1289	glutamine	glutamine	NN	I-NP
O	1290	1296	uptake	uptake	NN	I-NP
O	1297	1300	was	be	VBD	B-VP
O	1301	1311	maintained	maintain	VBN	I-VP
O	1312	1314	in	in	IN	B-PP
O	1315	1318	the	the	DT	I-PP
O	1319	1327	presence	presence	NN	I-PP
O	1328	1330	of	of	IN	I-PP
O	1331	1338	glucose	glucose	NN	B-NP
O	1338	1339	.	.	.	O

